1. Home
  2. FENC vs GF Comparison

FENC vs GF Comparison

Compare FENC & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FENC
  • GF
  • Stock Information
  • Founded
  • FENC 1996
  • GF 1990
  • Country
  • FENC United States
  • GF Germany
  • Employees
  • FENC N/A
  • GF N/A
  • Industry
  • FENC Biotechnology: Biological Products (No Diagnostic Substances)
  • GF Investment Managers
  • Sector
  • FENC Health Care
  • GF Finance
  • Exchange
  • FENC Nasdaq
  • GF Nasdaq
  • Market Cap
  • FENC 156.9M
  • GF 126.8M
  • IPO Year
  • FENC 2001
  • GF N/A
  • Fundamental
  • Price
  • FENC $6.49
  • GF $9.89
  • Analyst Decision
  • FENC Strong Buy
  • GF
  • Analyst Count
  • FENC 2
  • GF 0
  • Target Price
  • FENC $14.00
  • GF N/A
  • AVG Volume (30 Days)
  • FENC 55.8K
  • GF 28.1K
  • Earning Date
  • FENC 03-10-2025
  • GF 01-01-0001
  • Dividend Yield
  • FENC N/A
  • GF 0.82%
  • EPS Growth
  • FENC N/A
  • GF N/A
  • EPS
  • FENC N/A
  • GF N/A
  • Revenue
  • FENC $47,538,000.00
  • GF N/A
  • Revenue This Year
  • FENC $28.99
  • GF N/A
  • Revenue Next Year
  • FENC $63.21
  • GF N/A
  • P/E Ratio
  • FENC N/A
  • GF N/A
  • Revenue Growth
  • FENC 123.69
  • GF N/A
  • 52 Week Low
  • FENC $3.96
  • GF $7.38
  • 52 Week High
  • FENC $11.49
  • GF $9.41
  • Technical
  • Relative Strength Index (RSI)
  • FENC 47.98
  • GF 73.35
  • Support Level
  • FENC $5.75
  • GF $9.79
  • Resistance Level
  • FENC $7.06
  • GF $9.97
  • Average True Range (ATR)
  • FENC 0.33
  • GF 0.15
  • MACD
  • FENC -0.07
  • GF 0.05
  • Stochastic Oscillator
  • FENC 57.25
  • GF 81.61

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

About GF New Germany Fund Inc. (The)

NEW GERMANY FUND INC is a United States-based non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.

Share on Social Networks: